Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfreundschuh

Showing results (191-200 of 260) with videos related to

Pageof 26
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study GroupV Diehl, M Pfreundschuh, M Löffler, et al.
International Journal of Cancer|November 11, 1993
A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivoA Hombach, W Jung, C Pohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3L da Costa, P Carde, J D Lumbroso, et al.
Annals of Hematology|August 28, 2013
CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trialC Binder, M Ziepert, M Pfreundschuh, et al.
The Journal of Experimental Medicine|September 19, 1979
Cell surface antigens of human renal cancer defined by autologous typingR Ueda, H Shiku, M Pfreundschuh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2011
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study GroupN Schmitz, S Zeynalova, B Glass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Expression of cancer testis genes in human brain tumorsU Sahin, M Koslowski, O Türeci, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Risk factor adapted treatment of Hodgkin's lymphoma: strategies and perspectivesM Loeffler, M Pfreundschuh, U Rühl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2010
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group studyM Rieger, A Österborg, R Pettengell, et al.
International Journal of Andrology|February 1, 1987
Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycinH J Schmoll, I Schubert, H Arnold, et al.
Pageof 26

Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study GroupV Diehl, M Pfreundschuh, M Löffler, et al.
International Journal of Cancer|November 11, 1993
A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivoA Hombach, W Jung, C Pohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3L da Costa, P Carde, J D Lumbroso, et al.
Annals of Hematology|August 28, 2013
CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trialC Binder, M Ziepert, M Pfreundschuh, et al.
The Journal of Experimental Medicine|September 19, 1979
Cell surface antigens of human renal cancer defined by autologous typingR Ueda, H Shiku, M Pfreundschuh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2011
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study GroupN Schmitz, S Zeynalova, B Glass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Expression of cancer testis genes in human brain tumorsU Sahin, M Koslowski, O Türeci, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Risk factor adapted treatment of Hodgkin's lymphoma: strategies and perspectivesM Loeffler, M Pfreundschuh, U Rühl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2010
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group studyM Rieger, A Österborg, R Pettengell, et al.
International Journal of Andrology|February 1, 1987
Disseminated testicular cancer with bulky disease: results of a phase-II study with cisplatin ultra high dose/VP-16/bleomycinH J Schmoll, I Schubert, H Arnold, et al.
Pageof 26